查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1676707

GMP 级细胞培养基市场按成分、产品类型、细胞培养类型、细胞类型和应用划分 - 2025-2030 年全球预测

GMP Grade Cell Culture Media Market by Component, Product Type, Cell Culture Type, Cell Type, Application - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

GMP 级细胞培养基市场预计在 2024 年价值为 79.3 亿美元，到 2025 年以 9.99% 的复合年增长率增长至 87.1 亿美元，到 2030 年将达到 140.6 亿美元。

主要市场统计数据
基准年 2024 年 79.3亿美元
预计 2025 年 87.1亿美元
预测年份 2030 140.6亿美元
复合年增长率（%） 9.99％

GMP级细胞培养基是生物製药开发和科学研究进步的基石。在当今快速发展的生物技术环境中，严格的品质标准和对监管要求的遵守推动这些高等级培养基的作用。随着对产品製造一致性的需求不断增加以及对整体製程可靠性的相关影响，相关人员认识到 GMP 级介质是确保安全性和效能结果的关键要素。

实现这些标准不仅仅是满足监管清单的问题；它需要研究创新、流程优化和强大的品管的持续相互作用。在过去的十年中，对先进配方和技术创新的投资推动了 GMP 级培养基的发展。本介绍对直接影响市场动态的市场趋势和关键细分见解进行了全面的分析。我们将强调培养基品质所起的关键作用，讨论这些产品如何成为现代生物加工领域的重要组成部分，帮助减少广泛说明范围内的变异性并提高可重复性。

高等级细胞培养基的重要性也反映在组织工程、基因治疗和重组蛋白生产的精简通讯协定中。透过树立行业标桿，这些媒体不仅确保符合国际品质标准，而且还促进了推动整个产业发展的尖端研究。

此外，随着公司不断优化生产流程，对GMP级培养基的策略性投资已成为其研发工作的关键方面。本介绍为市场的多方面发展提供了清晰的背景，并强调了细胞培养应用领域的法律规范、技术创新和市场需求动态之间的内在联繫。

景观的变革

在生物技术的快速进步、监管环境的不断演变和全球对创新的关注的推动下，细胞培养基领域经历了变革性的转变。近年来，新技术的融合和不断发展的科学通讯协定重新定义了该行业。流程自动化、改进的分析技术和更紧密的即时监控系统整合都有助于提高细胞培养流程的操作流程和可重复性。

值得注意的是，随着监管机构完善其指导方针以更好地确保产品的安全性和有效性，製造商必须重新调整其生产方法。这种转变正在刺激下一代 GMP 级细胞培养基的开发，以满足大规模生物製药製造和复杂研究应用不断变化的需求。对品质和一致性的日益重视促使公司投入研究，从而开发出适合不同细胞类型和应用的培养基配方。

此外，全球合作与伙伴关係促进了生产设施之间的技术转移和标准化。因此，以前较慢采用尖端细胞培养方法的地区现在正在迅速赶上。这种转变不仅体现在产品创新上，也体现在如何产生、分析和利用流程资料来推动持续改进。现代製造技术正在促进以更具活力、更注重结果的方式来应对挑战，使技术能力与当今市场患者的高期望相结合。

先进的自动化、数位技术和目标驱动的思维方式的结合代表着模式转移，其中品质不再是一种可选属性，而是一项绝对要求。这些全行业的转型趋势为更永续的製造方法奠定了基础，并确保研究和生产能够跟上快速成长的市场需求。

关键市场区隔洞察

透过分析关键细分参数，可以增强对 GMP 级细胞培养基市场的整体了解，每个细分参数都可以提供有关市场动态和成长潜力的独特见解。从产品成分来看，市场正在对胺基酸、生长因子、荷尔蒙、微量元素和维生素进行深入探索。这种分类强调了内源性补充剂对于促进培养系统中细胞健康和生产力的重要性。它还强调了每个成分所起的微妙作用，使得培养基配方能够精确定制，以满足不同细胞株的特定营养需求。

就产品类型而言，市场格局是化学定义的、经典的、无蛋白质的、无血清的和特殊培养基的混合。每种分类都提供了一组独特的优势，可以满足不同的应用需求和操作工作流程。例如，化学成分明确的培养基具有无与伦比的一致性和降低的可变性，而特种培养基则可以针对标准配方不足的复杂应用进行客製化。这种多样化的选择不仅提供了灵活性，而且还凸显了市场对标准和客製化要求的应对力。

此外，根据细胞培养类型的细分可区分连续细胞培养、初代细胞培养和继发细胞培养。这种分类对于了解各种研究和生产设施所采用的操作技术和扩大规模策略至关重要。虽然连续细胞培养通常与长期、可扩展的生产相关，但初级和二级研究为更精细的早期研究和客製化应用提供了见解。

基于细胞类型的分割透过评估禽细胞、细菌细胞、昆虫细胞、哺乳动物细胞和酵母进一步缩小视野。每种细胞类型与其培养环境的相互作用不同，因此需要选择特定的成分和支持系统。例如，哺乳动物细胞培养对于重组蛋白的生产和治疗方法开发至关重要，对培养基成分和法规遵循有严格的要求。相较之下，细菌和酵母培养物需要支持快速生长和扩充性的配方。

深入研究应用，市场细分为生物製药生产、研发及组织工程。生物製药生产进一步细分为单株抗体生产、重组蛋白生产等领域。这些部分反映了治疗性蛋白质製造所需的日益复杂的程度和高标准。同时，研发领域进一步细分为 CRISPR 技术、基因治疗和干细胞研究，基因编辑扩展到农业改良和治疗开发。在组织工程领域，3D 细胞培养和再生医学等子类别的研究正在取得进一步进展，基于细胞的分析和类器官形成的进展代表着在创建更多生理相关模型方面取得了重大飞跃。每个细分层都错综复杂地交织在一起，不仅揭示了市场需求的多样性，也揭示了不断发展的创新格局，以全力支持前沿研究和强大的生产实践。

目录

第 1 章 简介

第二章调查方法

第三章执行摘要

第四章 市场概况

第五章 市场洞察

  • 市场动态
    • 驱动程式
      • 全球慢性病发生率不断上升
      • 细胞疫苗的细胞培养技术日益涌现
      • 严格的监管标准要求使用高品质的 GMP 级培养基进行药物开发
    • 限制因素
      • GMP 级细胞培养基的复杂品管要求
    • 机会
      • 个人化医疗趋势推动成长
      • 扩大GMP级细胞培养基在再生医学和细胞治疗的应用
    • 任务
      • 使用动物性来源产品的伦理问题
  • 市场区隔分析
    • 成分：维生素因其在维持细胞完整性和身体功能方面发挥的重要作用而变得越来越受欢迎。
    • 应用：扩大 GMP 级细胞培养基在组织工程的应用
  • 波特五力分析
  • PESTEL 分析
    • 政治的
    • 经济
    • 社会的
    • 技术的
    • 合法的
    • 环境

6. GMP 级细胞培养基市场（依成分）

  • 胺基酸
  • 生长因子
  • 荷尔蒙
  • 微量元素
  • 维他命

第 7 章 GMP 级细胞培养基市场（依产品类型）

  • 化学成分明确的培养基
  • 古典媒体
  • 无蛋白培养基
  • 无血清培养基
  • 专业媒体

8. GMP 级细胞培养基市场（依细胞培养类型）

  • 连续细胞培养
  • 初代细胞培养
  • 二次细胞培养

9. GMP 级细胞培养基市场（依细胞类型）

  • 禽类细胞
  • 细菌细胞
  • 昆虫细胞
  • 哺乳动物细胞
  • 酵母菌

第 10 章 GMP 级细胞培养基市场（依应用）

  • 生物製药製造
    • 单株抗体生产
    • 重组蛋白生产
  • 研究与开发
    • CRISPR 技术
      • 基因编辑
      • 农业改良
      • 治疗进展
    • 基因治疗
    • 干细胞研究
  • 组织工程
    • 3D 细胞培养
      • 基于细胞的检测
      • 类器官形成
    • 再生医学

第 11 章：美洲 GMP 级细胞培养基市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

12. 亚太地区 GMP 级细胞培养基市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

13. 欧洲、中东和非洲 GMP 级细胞培养基市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十四章 竞争格局

  • 2024 年市场占有率分析
  • FPNV 定位矩阵，2024 年
  • 竞争情境分析
  • 战略分析与建议

公司列表

  • Avantor, Inc.
  • Becton, Dickinson and Company
  • Bio-Techne Corporation
  • BioLife Solutions Inc.
  • CellGenix GmbH
  • Cook Group Incorporated
  • Corning Incorporated
  • Danaher Corporation
  • DWK Life Sciences GmbH
  • Eppendorf AG
  • Fujifilm Irvine Scientific
  • Gemini Bio-Products, Inc.
  • HiMedia Laboratories Pvt. Ltd
  • InVitria
  • Lonza Group
  • Merck KGaA
  • Miltenyi Biotec
  • MP Biomedicals
  • PromoCell GmbH
  • Sartorius AG
  • STEMCELL Technologies
  • Takara Bio Inc.
  • Thermo Fisher Scientific Inc.
Product Code: MRR-4F7A6D4FD889

The GMP Grade Cell Culture Media Market was valued at USD 7.93 billion in 2024 and is projected to grow to USD 8.71 billion in 2025, with a CAGR of 9.99%, reaching USD 14.06 billion by 2030.

KEY MARKET STATISTICS
Base Year [2024] USD 7.93 billion
Estimated Year [2025] USD 8.71 billion
Forecast Year [2030] USD 14.06 billion
CAGR (%) 9.99%

GMP grade cell culture media represent a cornerstone in the advancement of biopharmaceutical development and scientific research. In today's rapidly evolving biotech environment, stringent quality standards and adherence to regulatory requirements have elevated the role of these high-grade media. With the increasing need for consistency in product manufacturing and the subsequent impact on overall process reliability, stakeholders have recognized GMP grade media as a critical factor in ensuring both safety and performance outcomes.

The journey toward achieving these standards is not merely about meeting regulatory checklists but involves a continuous interplay of research innovation, process optimization, and robust quality management. Over the past decade, investments in advanced formulations and technology innovations have helped drive the evolution of GMP grade media. This introduction sets the stage for a comprehensive analysis of the market trends and critical segmentation insights that are directly influencing market dynamics. With an emphasis on the critical role of media quality, the narrative explains how these products have become an integral part of modern bioprocessing disciplines, helping reduce variability and enhancing reproducibility across diverse applications.

The significance of high-grade cell culture media is also reflected in the streamlined protocols for tissue engineering, gene therapy, and recombinant protein production. By setting industry benchmarks, these media not only ensure compliance with international quality standards but also facilitate cutting-edge research that propels the entire industry forward.

Furthermore, as companies continue to optimize their production processes, strategic investments in GMP grade media have become a vital aspect of research and development efforts. This introduction provides a clear context for the multifaceted evolution of the market, highlighting the inherent connections between regulatory frameworks, technological innovations, and market demand dynamics within the sphere of cell culture applications.

Transformative Shifts in the Landscape

The cell culture media landscape has experienced transformative shifts fuelled by rapid advancements in biotechnology, regulatory revisions, and a global focus on innovation. In recent years, the integration of emerging technologies and the evolution of scientific protocols have redefined industry norms. Improvements in process automation, enhanced analytics, and tighter integration of real-time monitoring systems have all contributed to more streamlined operations and higher reproducibility in cell culture processes.

Notably, as regulatory bodies refine guidelines to further ensure product safety and efficacy, manufacturers have had to recalibrate their production methods. These shifts have spurred the development of next-generation, GMP grade cell culture media that cater to the evolving needs of both large-scale biopharmaceutical production and intricate research applications. The emphasis on quality and consistency has driven companies to invest in research, resulting in media formulations tailored for a variety of cell types and applications.

In addition, global collaborations and partnerships have encouraged technology transfer and standardization across production facilities. As a result, even regions that previously lagged in adopting state-of-the-art cell culture practices are rapidly catching up. The transformation is evidenced not only in product innovation but also in the way process data is generated, analyzed, and utilized to drive continuous improvement. Modern manufacturing technologies are now promoting a more dynamic, outcome-oriented approach to challenges, aligning technological capabilities with the high expectations of today's market patients.

The convergence of advanced automation, digital technologies, and a purpose-driven mindset signifies a paradigm shift where quality is no longer an optional attribute but an absolute requirement. These industry-wide transformative trends are laying the groundwork for more sustainable manufacturing practices and ensuring that research and production keep pace with the rapid expansion of market needs.

Key Segmentation Insights for the Market

A holistic understanding of the GMP grade cell culture media market is enhanced by dissecting key segmentation parameters, each offering unique insights into market dynamics and growth potential. When looking at product components, the market is diligently studied across amino acids, growth factors, hormones, trace elements, and vitamins. This classification underlines the importance of intrinsic supplements that drive cell health and productivity in culture systems. It also highlights the nuanced role each component plays in ensuring that media formulations can be precisely tailored to meet the specific nutritional needs of various cell lines.

In the context of product type, the market landscape includes a blend of chemically defined media, classical media, protein-free media, serum-free media, and specialty media. Each of these classifications presents a distinct set of benefits, catering to diverse application demands and operational workflows. For instance, chemically defined media offer unparalleled consistency and reduced variability, while specialty media are customized for complex applications where standard formulations may fall short. This spectrum of options not only provides flexibility but also underscores the market's responsiveness to both standard and bespoke requirements.

Furthermore, segmentation based on cell culture type distinguishes between continuous cell culture, primary cell culture, and secondary cell culture. This categorization is essential in understanding the operational methodologies and scale-up strategies adopted by various research and production facilities. Continuous cell culture is often associated with long-term, scalable production, while primary and secondary cultures provide insight into more delicate, early-stage research and bespoke applications.

The segmentation based on cell type further refines our view by evaluating avian cells, bacterial cells, insect cells, mammalian cells, and yeast. Each cell type interacts differently with the media environment, thereby dictating the selection of specific components and supporting systems. For example, mammalian cell cultures, which are critical for recombinant protein production and therapeutic development, impose stringent requirements on media composition and regulatory compliance. In contrast, bacterial and yeast cultures demand formulations that support rapid growth and scalability.

Delving deeper into applications, the market is classified into biopharmaceutical production, research and development, and tissue engineering. Biopharmaceutical production is further subdivided into areas such as monoclonal antibodies production and recombinant proteins production. These segments reflect the increasing complexity and high standards required in therapeutic protein manufacturing. In parallel, the research and development segment is further refined into CRISPR technology, gene therapy, and stem cell research, with gene editing expanding across agricultural modification and therapeutic development. Tissue engineering sees further study in subcategories such as 3D cell culture and regenerative medicine, where the progression to cell-based assays and organoid formation illustrates a significant leap forward in creating more physiologically relevant models. Each segmentation layer interplays intricately to reveal not only the diversity of market demands but also the innovative landscape, which is evolving to support cutting-edge research and robust production methodologies across the board.

Based on Component, market is studied across Amino Acids, Growth Factors, Hormones, Trace Elements, and Vitamins.

Based on Product Type, market is studied across Chemically Defined Media, Classical Media, Protein-Free Media, Serum-Free Media, and Specialty Media.

Based on Cell Culture Type, market is studied across Continuous Cell Culture, Primary Cell Culture, and Secondary Cell Culture.

Based on Cell Type, market is studied across Avian Cells, Bacterial Cells, Insect Cells, Mammalian Cells, and Yeast.

Based on Application, market is studied across Biopharmaceutical Production, Research and Development, and Tissue Engineering. The Biopharmaceutical Production is further studied across Monoclonal Antibodies Production and Recombinant Proteins Production. The Research and Development is further studied across CRISPR Technology, Gene Therapy, and Stem Cell Research. The CRISPR Technology is further studied across Gene Editing. The Gene Editing is further studied across Agricultural Modification and Therapeutic Development. The Tissue Engineering is further studied across 3D Cell Culture and Regenerative Medicine. The 3D Cell Culture is further studied across Cell-Based Assay and Organoid Formation.

Key Regional Insights into Market Dynamics

When evaluating the global spread of GMP grade cell culture media, it is critical to assess regional variances that drive market expansion and innovation. In the Americas, strong investments in biopharmaceutical infrastructure and a legacy of research excellence offer a robust marketplace characterized by growing demands for advanced cell culture solutions and scalable production methods. These trends are largely propelled by the region's well-established network of research institutes and manufacturing facilities.

Across Europe, the Middle East and Africa, regulatory standards and the high emphasis on quality assurance have set the stage for rapid adaptations in cell culture media. In these regions, consistent public and private investments in biotechnology have paved the way for increased market penetration and adoption of novel media formulations that meet stringent quality criteria. These dynamics are supported by a mature ecosystem of research collaborations and a solid regulatory framework.

In Asia-Pacific, rapid industrialization accompanied by significant government initiatives to foster biotechnology innovation has resulted in this region emerging as a key hub for both research and production. The combination of rising healthcare demands, strategic collaborations, and increased public funding has contributed to the acceleration of GMP grade media adoption. This region displays a unique blend of traditional research practices and modern technological integration, making it a vibrant and rapidly evolving segment of the global market. Regional insights across these areas indicate that despite varied economic and regulatory landscapes, market leaders are focusing on quality improvement and innovation to address the diverse needs of their clientele.

Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Comprehensive Company Insights in the Industry

The picture of market competitiveness becomes clearer when one considers the influence of leading companies in the realm of GMP grade cell culture media. Industry frontrunners such as Avantor, Inc., Becton, Dickinson and Company, Bio-Techne Corporation, and BioLife Solutions Inc. have been instrumental in setting high benchmarks for product quality and operational integrity. The innovation landscape is further enriched by key players including CellGenix GmbH, Cook Group Incorporated, Corning Incorporated, Danaher Corporation, and DWK Life Sciences GmbH. These organizations have combined extensive research experience with state-of-the-art manufacturing processes to deliver products that meet rigorous international quality standards.

Additional market leaders such as Eppendorf AG, Fujifilm Irvine Scientific, and Gemini Bio-Products, Inc. continue to drive growth through strategic approaches that emphasize research collaboration and technological advancement. Their contributions, along with the pioneering work of HiMedia Laboratories Pvt. Ltd, InVitria, Lonza Group, Merck KGaA, and Miltenyi Biotec, highlight a competitive environment where innovation is directly linked to market performance. MP Biomedicals, PromoCell GmbH, Sartorius AG, STEMCELL Technologies, Takara Bio Inc., and Thermo Fisher Scientific Inc. also play crucial roles in shaping the landscape, reinforcing the industry's commitment to continuous improvement and global excellence. These companies, working in tandem with multidimensional research strategies, have catalyzed significant advancements in overall product quality and performance, thus laying the foundation for sustainable growth across the sector.

The report delves into recent significant developments in the GMP Grade Cell Culture Media Market, highlighting leading vendors and their innovative profiles. These include Avantor, Inc., Becton, Dickinson and Company, Bio-Techne Corporation, BioLife Solutions Inc., CellGenix GmbH, Cook Group Incorporated, Corning Incorporated, Danaher Corporation, DWK Life Sciences GmbH, Eppendorf AG, Fujifilm Irvine Scientific, Gemini Bio-Products, Inc., HiMedia Laboratories Pvt. Ltd, InVitria, Lonza Group, Merck KGaA, Miltenyi Biotec, MP Biomedicals, PromoCell GmbH, Sartorius AG, STEMCELL Technologies, Takara Bio Inc., and Thermo Fisher Scientific Inc.. Actionable Recommendations for Industry Leaders

In a rapidly evolving market where quality and innovation are constant imperatives, industry leaders are encouraged to adopt a multi-pronged approach to safeguard their competitive advantage. First and foremost, it is essential to invest in state-of-the-art research and development initiatives that are directly aligned with evolving regulatory demands and technological improvements. Embracing digital transformation, including automation and data analytics, can further enhance operational efficiencies and product consistency.

Moreover, fostering strategic collaborations with research institutions, biotech companies, and regulatory bodies can serve to streamline product development and ensure compliance with international standards. Leaders should also consider diversifying their product portfolios to include a balanced mix of chemically defined and specialty media. This not only mitigates risks associated with market volatility but also positions organizations to meet a range of client-specific needs.

Additionally, continuous training and upskilling of workforce capabilities in advanced bioprocessing techniques will be crucial. With the market becoming increasingly sophisticated, enhancing internal competencies through regular knowledge exchanges and technology workshops will facilitate the adoption of next-generation media formulations and quality control measures.

Investing in robust supply chain management systems and ensuring transparency in sourcing raw materials can further reinforce the integrity of product quality. Adapting customer-centric approaches by engaging with end-users and incorporating their feedback into product development will help in tailoring solutions that offer maximum efficacy and reliability. By seamlessly integrating these strategies, industry leaders can not only boost their market competitiveness but also contribute to setting new quality standards across the board.

Conclusion: A Transformative Era in Cell Culture Media

The evolution of GMP grade cell culture media encapsulates a transformative era defined by scientific innovation, stringent quality standards, and proactive regulatory frameworks. From foundational research to large-scale biopharmaceutical manufacturing, these media have become indispensable in driving advancements across multiple domains of biotechnology. The convergence of strategic investments in research and development, along with emerging technologies, is redefining the landscape, enabling enhanced product consistency and broadening application scopes.

The multi-dimensional segmentation-from fundamental components and product types to varied cell culture methodologies and regional market dynamics-offers a detailed perspective on how diverse market segments are interlinked and mutually reinforcing. Furthermore, the active roles played by leading companies in advancing technology, streamlining processes, and meeting demanding regulatory requirements underscore the synergistic efforts propelling industry growth.

In summary, the trajectory of GMP grade cell culture media is emblematic of a sector that is continually adapting to meet the demands of precision, efficiency, and quality. As the market progresses, stakeholders are presented with unprecedented opportunities for innovation and improvement, ensuring that the industry remains dynamic and responsive to future challenges.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of chronic diseases globally
      • 5.1.1.2. Growing emergence of cell culture technologies for cell-based vaccines
      • 5.1.1.3. Stringent regulatory standards mandating use of high-quality GMP grade media for drug development
    • 5.1.2. Restraints
      • 5.1.2.1. Complex quality control requirements in the GMP grade cell culture media
    • 5.1.3. Opportunities
      • 5.1.3.1. Growing trend toward personalized medicine fueling growth
      • 5.1.3.2. Expanding GMP grade cell culture media applications in regenerative medicine and cell therapy
    • 5.1.4. Challenges
      • 5.1.4.1. Ethical issues concerning the use of animal-derived products
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Component: Increasing preference for vitamins due to their essential role in maintaining cellular integrity and functioning of the body
    • 5.2.2. Application: Expanding application of GMP grade cell culture media in tissue engineering
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. GMP Grade Cell Culture Media Market, by Component

  • 6.1. Introduction
  • 6.2. Amino Acids
  • 6.3. Growth Factors
  • 6.4. Hormones
  • 6.5. Trace Elements
  • 6.6. Vitamins

7. GMP Grade Cell Culture Media Market, by Product Type

  • 7.1. Introduction
  • 7.2. Chemically Defined Media
  • 7.3. Classical Media
  • 7.4. Protein-Free Media
  • 7.5. Serum-Free Media
  • 7.6. Specialty Media

8. GMP Grade Cell Culture Media Market, by Cell Culture Type

  • 8.1. Introduction
  • 8.2. Continuous Cell Culture
  • 8.3. Primary Cell Culture
  • 8.4. Secondary Cell Culture

9. GMP Grade Cell Culture Media Market, by Cell Type

  • 9.1. Introduction
  • 9.2. Avian Cells
  • 9.3. Bacterial Cells
  • 9.4. Insect Cells
  • 9.5. Mammalian Cells
  • 9.6. Yeast

10. GMP Grade Cell Culture Media Market, by Application

  • 10.1. Introduction
  • 10.2. Biopharmaceutical Production
    • 10.2.1. Monoclonal Antibodies Production
    • 10.2.2. Recombinant Proteins Production
  • 10.3. Research and Development
    • 10.3.1. CRISPR Technology
      • 10.3.1.1. Gene Editing
      • 10.3.1.1.1. Agricultural Modification
      • 10.3.1.1.2. Therapeutic Development
    • 10.3.2. Gene Therapy
    • 10.3.3. Stem Cell Research
  • 10.4. Tissue Engineering
    • 10.4.1. 3D Cell Culture
      • 10.4.1.1. Cell-Based Assay
      • 10.4.1.2. Organoid Formation
    • 10.4.2. Regenerative Medicine

11. Americas GMP Grade Cell Culture Media Market

  • 11.1. Introduction
  • 11.2. Argentina
  • 11.3. Brazil
  • 11.4. Canada
  • 11.5. Mexico
  • 11.6. United States

12. Asia-Pacific GMP Grade Cell Culture Media Market

  • 12.1. Introduction
  • 12.2. Australia
  • 12.3. China
  • 12.4. India
  • 12.5. Indonesia
  • 12.6. Japan
  • 12.7. Malaysia
  • 12.8. Philippines
  • 12.9. Singapore
  • 12.10. South Korea
  • 12.11. Taiwan
  • 12.12. Thailand
  • 12.13. Vietnam

13. Europe, Middle East & Africa GMP Grade Cell Culture Media Market

  • 13.1. Introduction
  • 13.2. Denmark
  • 13.3. Egypt
  • 13.4. Finland
  • 13.5. France
  • 13.6. Germany
  • 13.7. Israel
  • 13.8. Italy
  • 13.9. Netherlands
  • 13.10. Nigeria
  • 13.11. Norway
  • 13.12. Poland
  • 13.13. Qatar
  • 13.14. Russia
  • 13.15. Saudi Arabia
  • 13.16. South Africa
  • 13.17. Spain
  • 13.18. Sweden
  • 13.19. Switzerland
  • 13.20. Turkey
  • 13.21. United Arab Emirates
  • 13.22. United Kingdom

14. Competitive Landscape

  • 14.1. Market Share Analysis, 2024
  • 14.2. FPNV Positioning Matrix, 2024
  • 14.3. Competitive Scenario Analysis
    • 14.3.1. SEKISUI Diagnostics completed a pound 15.7 million expansion at its UK site
    • 14.3.2. REPROCELL USA inaugurated a GMP manufacturing facility in Maryland, enhancing its capabilities in producing hiPSC and hMSC
    • 14.3.3. BASF Pharma Solutions introduces Kolliphor P188 Cell Culture to enhance cell viability and density
  • 14.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Avantor, Inc.
  • 2. Becton, Dickinson and Company
  • 3. Bio-Techne Corporation
  • 4. BioLife Solutions Inc.
  • 5. CellGenix GmbH
  • 6. Cook Group Incorporated
  • 7. Corning Incorporated
  • 8. Danaher Corporation
  • 9. DWK Life Sciences GmbH
  • 10. Eppendorf AG
  • 11. Fujifilm Irvine Scientific
  • 12. Gemini Bio-Products, Inc.
  • 13. HiMedia Laboratories Pvt. Ltd
  • 14. InVitria
  • 15. Lonza Group
  • 16. Merck KGaA
  • 17. Miltenyi Biotec
  • 18. MP Biomedicals
  • 19. PromoCell GmbH
  • 20. Sartorius AG
  • 21. STEMCELL Technologies
  • 22. Takara Bio Inc.
  • 23. Thermo Fisher Scientific Inc.

LIST OF FIGURES

  • FIGURE 1. GMP GRADE CELL CULTURE MEDIA MARKET MULTI-CURRENCY
  • FIGURE 2. GMP GRADE CELL CULTURE MEDIA MARKET MULTI-LANGUAGE
  • FIGURE 3. GMP GRADE CELL CULTURE MEDIA MARKET RESEARCH PROCESS
  • FIGURE 4. GMP GRADE CELL CULTURE MEDIA MARKET SIZE, 2024 VS 2030
  • FIGURE 5. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 6. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 7. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2024 VS 2030 (%)
  • FIGURE 9. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2030 (%)
  • FIGURE 11. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL CULTURE TYPE, 2024 VS 2030 (%)
  • FIGURE 13. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL CULTURE TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 14. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2024 VS 2030 (%)
  • FIGURE 15. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 16. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2024 VS 2030 (%)
  • FIGURE 17. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 18. AMERICAS GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 19. AMERICAS GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 20. UNITED STATES GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY STATE, 2024 VS 2030 (%)
  • FIGURE 21. UNITED STATES GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 22. ASIA-PACIFIC GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 23. ASIA-PACIFIC GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 24. EUROPE, MIDDLE EAST & AFRICA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
  • FIGURE 25. EUROPE, MIDDLE EAST & AFRICA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
  • FIGURE 26. GMP GRADE CELL CULTURE MEDIA MARKET SHARE, BY KEY PLAYER, 2024
  • FIGURE 27. GMP GRADE CELL CULTURE MEDIA MARKET, FPNV POSITIONING MATRIX, 2024

LIST OF TABLES

  • TABLE 1. GMP GRADE CELL CULTURE MEDIA MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
  • TABLE 3. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. GMP GRADE CELL CULTURE MEDIA MARKET DYNAMICS
  • TABLE 7. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY AMINO ACIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY GROWTH FACTORS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY HORMONES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY TRACE ELEMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY VITAMINS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CHEMICALLY DEFINED MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CLASSICAL MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PROTEIN-FREE MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY SERUM-FREE MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY SPECIALTY MEDIA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL CULTURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CONTINUOUS CELL CULTURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRIMARY CELL CULTURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY SECONDARY CELL CULTURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY AVIAN CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BACTERIAL CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY INSECT CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY MAMMALIAN CELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY YEAST, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY MONOCLONAL ANTIBODIES PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RECOMBINANT PROTEINS PRODUCTION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 34. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH AND DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CRISPR TECHNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 36. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY GENE EDITING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 37. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY AGRICULTURAL MODIFICATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 38. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY THERAPEUTIC DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 39. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
  • TABLE 40. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CRISPR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 41. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY GENE THERAPY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 42. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY STEM CELL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 43. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 44. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY TISSUE ENGINEERING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 45. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY 3D CELL CULTURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 46. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL-BASED ASSAY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 47. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY ORGANOID FORMATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 48. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 49. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 50. GLOBAL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 51. AMERICAS GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 52. AMERICAS GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. AMERICAS GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL CULTURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 54. AMERICAS GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. AMERICAS GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. AMERICAS GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 57. AMERICAS GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 58. AMERICAS GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CRISPR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 59. AMERICAS GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
  • TABLE 60. AMERICAS GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 61. AMERICAS GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 62. AMERICAS GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 63. ARGENTINA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 64. ARGENTINA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. ARGENTINA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL CULTURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. ARGENTINA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 67. ARGENTINA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 68. ARGENTINA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 69. ARGENTINA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 70. ARGENTINA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CRISPR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 71. ARGENTINA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
  • TABLE 72. ARGENTINA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 73. ARGENTINA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 74. BRAZIL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 75. BRAZIL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. BRAZIL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL CULTURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. BRAZIL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. BRAZIL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. BRAZIL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 80. BRAZIL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 81. BRAZIL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CRISPR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 82. BRAZIL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
  • TABLE 83. BRAZIL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 84. BRAZIL GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 85. CANADA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 86. CANADA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 87. CANADA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL CULTURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. CANADA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. CANADA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 90. CANADA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 91. CANADA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 92. CANADA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CRISPR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 93. CANADA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
  • TABLE 94. CANADA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 95. CANADA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 96. MEXICO GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 97. MEXICO GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. MEXICO GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL CULTURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. MEXICO GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. MEXICO GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. MEXICO GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 102. MEXICO GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 103. MEXICO GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CRISPR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 104. MEXICO GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
  • TABLE 105. MEXICO GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 106. MEXICO GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 107. UNITED STATES GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 108. UNITED STATES GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. UNITED STATES GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL CULTURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. UNITED STATES GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 111. UNITED STATES GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. UNITED STATES GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 113. UNITED STATES GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 114. UNITED STATES GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CRISPR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 115. UNITED STATES GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
  • TABLE 116. UNITED STATES GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 117. UNITED STATES GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 118. UNITED STATES GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 119. ASIA-PACIFIC GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 120. ASIA-PACIFIC GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 121. ASIA-PACIFIC GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL CULTURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. ASIA-PACIFIC GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. ASIA-PACIFIC GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 124. ASIA-PACIFIC GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 125. ASIA-PACIFIC GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 126. ASIA-PACIFIC GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CRISPR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 127. ASIA-PACIFIC GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
  • TABLE 128. ASIA-PACIFIC GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 131. AUSTRALIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 132. AUSTRALIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 133. AUSTRALIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL CULTURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. AUSTRALIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 135. AUSTRALIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 136. AUSTRALIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 137. AUSTRALIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 138. AUSTRALIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CRISPR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 139. AUSTRALIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
  • TABLE 140. AUSTRALIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 141. AUSTRALIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 142. CHINA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 143. CHINA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. CHINA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL CULTURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. CHINA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. CHINA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. CHINA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 148. CHINA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 149. CHINA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CRISPR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 150. CHINA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
  • TABLE 151. CHINA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 152. CHINA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 153. INDIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 154. INDIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. INDIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL CULTURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. INDIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 157. INDIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. INDIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 159. INDIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 160. INDIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CRISPR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 161. INDIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
  • TABLE 162. INDIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 163. INDIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 164. INDONESIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 165. INDONESIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. INDONESIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL CULTURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 167. INDONESIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 168. INDONESIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 169. INDONESIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 170. INDONESIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 171. INDONESIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CRISPR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 172. INDONESIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
  • TABLE 173. INDONESIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 174. INDONESIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 175. JAPAN GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 176. JAPAN GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 177. JAPAN GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL CULTURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. JAPAN GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. JAPAN GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 180. JAPAN GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 181. JAPAN GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 182. JAPAN GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CRISPR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 183. JAPAN GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
  • TABLE 184. JAPAN GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 185. JAPAN GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 186. MALAYSIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 187. MALAYSIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 188. MALAYSIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL CULTURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. MALAYSIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. MALAYSIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 191. MALAYSIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 192. MALAYSIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 193. MALAYSIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CRISPR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 194. MALAYSIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
  • TABLE 195. MALAYSIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 196. MALAYSIA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 197. PHILIPPINES GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 198. PHILIPPINES GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. PHILIPPINES GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL CULTURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. PHILIPPINES GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. PHILIPPINES GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 202. PHILIPPINES GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 203. PHILIPPINES GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 204. PHILIPPINES GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CRISPR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 205. PHILIPPINES GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
  • TABLE 206. PHILIPPINES GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 207. PHILIPPINES GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 208. SINGAPORE GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 209. SINGAPORE GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. SINGAPORE GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL CULTURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. SINGAPORE GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 212. SINGAPORE GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 213. SINGAPORE GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 214. SINGAPORE GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 215. SINGAPORE GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CRISPR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 216. SINGAPORE GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
  • TABLE 217. SINGAPORE GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 218. SINGAPORE GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 219. SOUTH KOREA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 220. SOUTH KOREA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. SOUTH KOREA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL CULTURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 222. SOUTH KOREA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 223. SOUTH KOREA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 224. SOUTH KOREA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 225. SOUTH KOREA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 226. SOUTH KOREA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CRISPR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 227. SOUTH KOREA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
  • TABLE 228. SOUTH KOREA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 229. SOUTH KOREA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 230. TAIWAN GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 231. TAIWAN GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 232. TAIWAN GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL CULTURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 233. TAIWAN GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 234. TAIWAN GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 235. TAIWAN GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 236. TAIWAN GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 237. TAIWAN GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CRISPR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 238. TAIWAN GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
  • TABLE 239. TAIWAN GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 240. TAIWAN GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 241. THAILAND GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 242. THAILAND GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 243. THAILAND GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL CULTURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 244. THAILAND GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 245. THAILAND GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 246. THAILAND GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 247. THAILAND GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 248. THAILAND GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CRISPR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 249. THAILAND GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
  • TABLE 250. THAILAND GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 251. THAILAND GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 252. VIETNAM GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 253. VIETNAM GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 254. VIETNAM GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL CULTURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 255. VIETNAM GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 256. VIETNAM GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 257. VIETNAM GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 258. VIETNAM GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 259. VIETNAM GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CRISPR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 260. VIETNAM GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
  • TABLE 261. VIETNAM GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 262. VIETNAM GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 263. EUROPE, MIDDLE EAST & AFRICA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 264. EUROPE, MIDDLE EAST & AFRICA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 265. EUROPE, MIDDLE EAST & AFRICA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL CULTURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 266. EUROPE, MIDDLE EAST & AFRICA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 267. EUROPE, MIDDLE EAST & AFRICA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 268. EUROPE, MIDDLE EAST & AFRICA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 269. EUROPE, MIDDLE EAST & AFRICA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 270. EUROPE, MIDDLE EAST & AFRICA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CRISPR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 271. EUROPE, MIDDLE EAST & AFRICA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
  • TABLE 272. EUROPE, MIDDLE EAST & AFRICA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 273. EUROPE, MIDDLE EAST & AFRICA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 274. EUROPE, MIDDLE EAST & AFRICA GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 275. DENMARK GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 276. DENMARK GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 277. DENMARK GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL CULTURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 278. DENMARK GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 279. DENMARK GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 280. DENMARK GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 281. DENMARK GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 282. DENMARK GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CRISPR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 283. DENMARK GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
  • TABLE 284. DENMARK GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 285. DENMARK GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 286. EGYPT GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 287. EGYPT GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 288. EGYPT GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL CULTURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 289. EGYPT GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 290. EGYPT GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 291. EGYPT GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 292. EGYPT GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 293. EGYPT GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CRISPR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 294. EGYPT GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
  • TABLE 295. EGYPT GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY TISSUE ENGINEERING, 2018-2030 (USD MILLION)
  • TABLE 296. EGYPT GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY 3D CELL CULTURE, 2018-2030 (USD MILLION)
  • TABLE 297. FINLAND GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY COMPONENT, 2018-2030 (USD MILLION)
  • TABLE 298. FINLAND GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY PRODUCT TYPE, 2018-2030 (USD MILLION)
  • TABLE 299. FINLAND GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL CULTURE TYPE, 2018-2030 (USD MILLION)
  • TABLE 300. FINLAND GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CELL TYPE, 2018-2030 (USD MILLION)
  • TABLE 301. FINLAND GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 302. FINLAND GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY BIOPHARMACEUTICAL PRODUCTION, 2018-2030 (USD MILLION)
  • TABLE 303. FINLAND GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY RESEARCH AND DEVELOPMENT, 2018-2030 (USD MILLION)
  • TABLE 304. FINLAND GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY CRISPR TECHNOLOGY, 2018-2030 (USD MILLION)
  • TABLE 305. FINLAND GMP GRADE CELL CULTURE MEDIA MARKET SIZE, BY GENE EDITING, 2018-2030 (USD MILLION)
  • TABLE 306. FINLAND GMP GRA